澳大拉西亚传染病学会发布的关于澳大利亚和新西兰成人及儿童艰难梭菌感染管理的最新指南。
Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand.
作者信息
Trubiano J A, Cheng A C, Korman T M, Roder C, Campbell A, May M L A, Blyth C C, Ferguson J K, Blackmore T K, Riley T V, Athan E
机构信息
Infectious Diseases Department, Austin Health, Melbourne, Western Australia.
Infectious Diseases Department, Peter MacCallum Cancer Centre, Melbourne, Western Australia.
出版信息
Intern Med J. 2016 Apr;46(4):479-93. doi: 10.1111/imj.13027.
The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.
艰难梭菌感染(CDI)的发病率持续上升,而由于疾病的复发性、难治性和潜在严重性,治疗仍然存在问题。艰难梭菌的治疗对社区和医院的临床医生来说是一项挑战。自上次发布澳大利亚指南以来,针对艰难梭菌的治疗手段不断增加,因此需要为澳大利亚临床医生更新CDI治疗建议。我们代表澳大利亚传染病协会,提出成人和儿童CDI管理的最新指南。